Ameriprise’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.9M Buy
+5,050,505
New +$4.82M ﹤0.01% 2885

Other funds holding OTLK

Ameriprise's OTLK Position: Q3 2026 in Review

Ameriprise opened a new position in Outlook Therapeutics (OTLK) in Q3 2026: 5,050,505 shares worth $2.9M. The stake represents ﹤0.01% of the portfolio and ranks #2885 among its holdings.

81 funds tracked by Wall St. Rank hold OTLK as of Q3 2026.

  • Ameriprise held 5,050,505 shares of Outlook Therapeutics worth $2.9M as of Q3 2026.
  • Outlook Therapeutics was a new Ameriprise position in Q3 2026.
  • Outlook Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #2885 holding.
  • 81 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2026.

Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.